Ian Bosdet's Avatar

Ian Bosdet

@exon

Geneticist @BCCancer, Associate Professor @UBC, mediocre photographer, soccer dad, data science hobbyist. I've had all my shots. Opinions are barely even mine.

144
Followers
721
Following
6
Posts
10.11.2023
Joined
Posts Following

Latest posts by Ian Bosdet @exon

Thanks for all the work that you and @mike-thomas.bsky.social put into this. I’m a complete #R beginner and your podcast has quickly become a highlight of my week.

04.12.2024 13:56 πŸ‘ 2 πŸ” 1 πŸ’¬ 1 πŸ“Œ 0

Great idea! I was just looking around for one and couldn’t find anything.

04.12.2024 13:40 πŸ‘ 0 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Preview
Minimal residual disease as a target for liquid biopsy in patients with solid tumours - Nature Reviews Clinical Oncology Liquid biopsy, or the analysis of tumour-derived or tumour-induced cells or cellular products in the blood or other body fluids, is a promising approach to assess minimal residual disease (MRD; also k...

MRD (minimal/measurable/molecular residual disease) is a staple of #hematologic #cancer testing. We use sensitive assays to detect #tumour #DNA in the blood, for treatment response monitoring and relapse prediction. Soon we'll be doing this for solid tumours too. www.nature.com/articles/s41...

02.12.2024 23:54 πŸ‘ 2 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Preview
Clinical Laboratory Geneticist Cancer Genetics & Genomics Laboratory Department of Pathology and Laboratory Medicine - BC Cancer - Vancouver at PHSA Learn more about applying for Clinical Laboratory Geneticist Cancer Genetics & Genomics Laboratory Department of Pathology and Laboratory Medicine - BC Cancer - Vancouver at PHSA

Are you #CCMG and/or #ABMGG certified and considering a move to beautiful Vancouver? Come join my team at BC Cancer! We do germline and somatic testing across a wide range of solid and hematologic cancers using some of the latest molecular and cytogenetic technologies. jobs.phsa.ca/job/vancouve...

11.11.2024 19:28 πŸ‘ 3 πŸ” 1 πŸ’¬ 0 πŸ“Œ 0
Preview
Secondary ACMG and non-ACMG genetic findings in a multiethnic cohort of 16,713 pediatric participants Clinical next-generation sequencing is an effective approach for identifying pathogenic sequence variants that are medically actionable for participants and families but are not associated with the pa...

Whole-genome sequencing in a large cohort of paediatric patients has a 9% secondary finding rate. My lab is just now transitioning our adult germline testing to a WGS backbone, and peds is coming soon, so I’m reading this with interest and some trepidation.

www.gimjournal.org/article/S109...

11.11.2024 19:08 πŸ‘ 3 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Video thumbnail

They shall grow not old,
as we that are left grow old:Β 
Age shall not weary them,
nor the years condemn.
At the going down of the sun
and in the morning
We will remember them.
β€”Lawrence Binyon

#RemembranceDay2024

11.11.2024 19:00 πŸ‘ 3 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0